Published in Am J Trop Med Hyg on December 01, 1999
Natural infection of synathropic rodent species Mus musculus and Rattus norvegicus by Leishmania infantum in Sesimbra and Sintra--Portugal. Parasit Vectors (2013) 0.87
Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS Negl Trop Dis (2012) 0.86
Black rat ( Rattus rattus) genomic variability characterized by chromosome painting. Mamm Genome (2002) 0.83
Rattus norvegicus (Rodentia: Muridae) Infected by Leishmania (Leishmania) infantum (syn. Le. chagasi) in Brazil. Biomed Res Int (2014) 0.78
Proceedings: Causes of death in cancer patients. Cancer (1974) 4.56
Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer (1972) 4.47
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun (2001) 2.72
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol (2004) 2.70
Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry (2008) 2.49
Clinical pharmacology of ticarcillin (alpha-carboxyl-3-thienylmethyl penicillin, BRL-2288). Antimicrob Agents Chemother (1973) 2.47
Carbenicillin therapy for pseudomonas infections. JAMA (1971) 2.40
Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol (2012) 2.31
Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci (1969) 2.25
Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity. Antimicrob Agents Chemother (1976) 2.12
Ticarcillin therapy of infections. Antimicrob Agents Chemother (1973) 2.01
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med (1979) 1.86
Paramutagenic Systems in Some South American Races of Corn. Genetics (1965) 1.76
Serratia sp. infections in cancer patients. Cancer (1970) 1.73
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun (2000) 1.68
[Standardized laparoscopic hernioplasty vs. Shouldice repair. Results of a randomized comparative study]. Chirurg (1995) 1.65
Causes of death in adults with acute leukemia. Medicine (Baltimore) (1976) 1.65
The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica (2001) 1.62
Clinical pharmacology of sisomicin. Antimicrob Agents Chemother (1975) 1.61
The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1993) 1.58
Posttraumatic stress disorder in a clinical sample of adults sexually abused as children. Child Abuse Negl (1994) 1.56
Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin Exp Immunol (1974) 1.54
Domestic and peridomestic transmission of American cutaneous leishmaniasis: changing epidemiological patterns present new control opportunities. Mem Inst Oswaldo Cruz (2001) 1.50
Testing non-linearity and directedness of interactions between neural groups in the macaque inferotemporal cortex. J Neurosci Methods (1999) 1.49
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Therapeutic trials with tobramycin. Am J Med Sci (1974) 1.44
Pharmacology of amikacin in humans. Antimicrob Agents Chemother (1974) 1.43
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol (2007) 1.42
Miconazole therapy for treatment of fungal infections in cancer patients. Antimicrob Agents Chemother (1979) 1.41
Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. Int J Lepr Other Mycobact Dis (1982) 1.41
Switching attention without shifting the spotlight object-based attentional modulation of brain potentials. J Cogn Neurosci (1998) 1.37
Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg (2000) 1.37
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore) (1979) 1.36
Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer (1978) 1.34
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1990) 1.30
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol (2009) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Clin Exp Immunol (1979) 1.26
Causes of death in patients with malignant lymphoma. Am J Med Sci (1974) 1.25
Neural correlates of working memory in Temporal Lobe Epilepsy--an fMRI study. Neuroimage (2012) 1.25
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet (1987) 1.24
Biobehavioral factors are associated with obesity in Puerto Rican children. J Nutr (2000) 1.23
Clinical pharmacological studies of carbenicillin. Am J Med Sci (1969) 1.20
Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion. Antimicrob Agents Chemother (1975) 1.20
A novel cytokinin-resistant mutant of Arabidopsis with abbreviated shoot development. Planta (1995) 1.18
Advances in the management of Pseudomonas aeruginosa infections in cancer patients. Eur J Cancer (1973) 1.17
Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread. J Virol (2000) 1.17
Suppression of polarity of insertion mutations in the gal operon and N mutations in bacteriophage lambda. J Bacteriol (1976) 1.17
Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg (1996) 1.15
Lymphocyte transformation with phytomitogens in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.15
Formation of lambda lysogens by IS2 recombination: gal operon--lambda pR promoter fusions. Virology (1979) 1.15
Therapy of infections with the combination of carbenicillin and gentamicin. Antimicrob Agents Chemother (Bethesda) (1969) 1.14
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol (2007) 1.13
Pomp combination chemotherapy of adult acute leukemia. Cancer (1973) 1.13
Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) (1978) 1.12
Chemotherapy of malignant lymphoma with adriamycin. Cancer Res (1973) 1.11
The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur J Obstet Gynecol Reprod Biol (1999) 1.11
Acute infections in cancer patients. Semin Oncol (1978) 1.10
Death at the border. Int Migr Rev (1999) 1.10
Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: discussion. J Thromb Haemost (2015) 1.06
Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother (1979) 1.06
Effect of the position of a basic amino acid on C-terminal rearrangement of protonated peptides upon collision-induced dissociation. J Mass Spectrom (1996) 1.06
Amikacin therapy of infections in neutropenic patients. Am J Med Sci (1976) 1.05
Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis (1981) 1.05
Production of monoclonal mouse IgE antibodies with DNP specificity by hybrid cell lines. Int Arch Allergy Appl Immunol (1980) 1.05
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol (2000) 1.05
Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients. Transplant Proc (1973) 1.04
Phylogeography of the neotropical sand fly Lutzomyia longipalpis inferred from mitochondrial DNA sequences. Infect Genet Evol (2002) 1.04
Infections in cancer patients on a protected environment-prophylactic antibiotic program. Am J Med (1975) 1.04
Recurrence after endoscopic transperitoneal hernia repair (TAPP): causes, reparative techniques, and results of the reoperation. J Am Coll Surg (2000) 1.04
Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99. Trans R Soc Trop Med Hyg (2004) 1.03
Distribution of bacteria in the epidermal layers and hair follicles of the human skin. Skin Pharmacol Physiol (2011) 1.03
Interspecies electro-transformation in Corynebacteria. FEMS Microbiol Lett (1990) 1.02
IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int J Lepr Other Mycobact Dis (1991) 1.02
Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl Hyg Umweltmed (1991) 1.01
Trefoil factor family domain peptides in the human respiratory tract. J Pathol (2000) 1.01
High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study. J Clin Oncol (1987) 1.00
Ectopic skin lesions produced by Schistosoma mansoni. Am J Trop Med Hyg (1973) 1.00
Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis (1989) 0.99
Wing shape divergence between Rhodnius prolixus from Cojedes (Venezuela) and Rhodnius robustus from Mérida (Venezuela). Infect Genet Evol (2002) 0.99
Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654). Antimicrob Agents Chemother (1974) 0.99
Laparoscopic hernia repair--TAPP or/and TEP? Langenbecks Arch Surg (2005) 0.98
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clin Oncol (1987) 0.98
Gentamicin sulfate distribution in body fluids. Clin Pharmacol Ther (1970) 0.98
Value of a dipstick based on recombinant RK39 antigen for differential diagnosis of American visceral leishmaniasis from other sympatric endemic diseases in Venezuela. Parasite (2001) 0.97
Scrotal hernias: a contraindication for an endoscopic procedure? Results of a single-institution experience in transabdominal preperitoneal repair. Surg Endosc (2000) 0.97
Vaccination in leprosy--observations and interpretations. Int J Lepr Other Mycobact Dis (1980) 0.96
Management of fever of unknown origin in patients with neoplasms and neutropenia. Cancer (1973) 0.95
Immunosuppressants: neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp Neurol (2005) 0.95
Oral complications of cancer chemotherapy. Postgrad Med (1975) 0.94
Disrupted segregation of working memory networks in temporal lobe epilepsy. Neuroimage Clin (2013) 0.93
Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements. Trans R Soc Trop Med Hyg (2005) 0.93
BCG vaccination protects against leprosy in Venezuela: a case-control study. Int J Lepr Other Mycobact Dis (1993) 0.92
A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell Mol Biol (Noisy-le-grand) (1995) 0.92
The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response. Parasite Immunol (1996) 0.92
DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J Gen Virol (2000) 0.92